Immunocore Holdings plc will participate in several investor conferences in March 2026, including a presentation at the TD Cowen 46th Annual Healthcare Conference on March 3, 2026, and a fireside chat at the Leerink 2026 Global Healthcare Conference on March 9, 2026, along with investor meetings at the Barclays 28th Annual Global Healthcare Conference (March 10, 2026), UBS Biotech Summit Miami, Catalyst for Change (March 10, 2026), and Jefferies 2026 Biotech on the Beach Summit (March 11, 2026). Where available, webcasts and replays can be accessed via the Investors section of the company website: https://www.immunocore.com and the company announcement page: https://www.globenewswire.com/Tracker?data=UUX0ogE3_M2EKJBhzK01Vlr5ltQ_AH90E4FrNBsUnShLOHMPZh-y1MeDGmnYeTnOQVlS_WRgUhWyKIezaFln10GUpVjrf_BV-diNrtvuXs-F15eiTuydN32RPrcNoO-GB9fXrSfHC2lt268QMZIQXHs7ERrFCUn-SKWjpX-smEaxYHXf498UUiNtfkc2sItZ
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunocore Holdings plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603030700PRIMZONEFULLFEED1001167874) on March 03, 2026, and is solely responsible for the information contained therein.